# Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis

> **NCT01357486** · PHASE2 · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 160 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- CHILD B

## Interventions

- **DRUG:** sorafenib
- **DRUG:** Pravastatin
- **DRUG:** Sorafenib + Pravastatin
- **OTHER:** patients receiving best supportive care

## Key facts

- **NCT ID:** NCT01357486
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11-14
- **Primary completion:** 2017-04-12
- **Final completion:** 2017-04-12
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2017-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357486, "Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01357486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*